dFDA LogoFDA.gov v2

Clinical Trials for Type 2 Diabetes

Focusing on: SGLT2 Inhibitors

Specify a medical condition you are interested in.

Specify a drug, device, or procedure if you are looking for trials for a specific intervention.

Displaying 10 of 691 results.

Page 1 of 70

SGLT2 Inhibitors and Effects on Hematopoiesis, Inflammation and Metabolic Markers

Active, Not Recruiting
Interventions:SGLT2 inhibitor
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 80
Age: From 18 Years
Gender: ALL
Locations: University Hospital of Patras
Last Updated: N/A
View Study Details

SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study

Recruiting
Interventions:SGLT2 inhibitor
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 1000
Age: From 19 Years
Gender: ALL
Locations: Seoul St. Mary's Hospital
Last Updated: N/A
Join Study

SGLT-2 Inhibitors in the Treatment of Ascites

Recruiting
Interventions:SGLT2 inhibitor
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 40
Age: 18 Years - 80 Years
Gender: ALL
Locations: Internal Medicine Unit, V. Cervello Hospital; Department of Internal Medicine, University Hospital of Palermo
Last Updated: N/A
Join Study

The Effect of SGLT-2 Inhibitor in Patient With Atrial Fibrillation and Diabetes Mellitus

ENROLLING_BY_INVITATION
Interventions:SGLT2 inhibitor
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 716
Age: 20 Years - 80 Years
Gender: ALL
Locations: Ewha womans university mokdong hospital
Last Updated: N/A
View Study Details

Performance Under SGLT-2-Inhibitors in Humans

Completed
Interventions:N/A
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 450
Age: From 40 Years
Gender: ALL
Locations: Berner Klinik Montana
Last Updated: N/A
View Study Details

Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists

Completed
Conditions:Type 2 Diabetes
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 10000
Age: 18 Years - 90 Years
Gender: ALL
Locations: Division of Metabolic Diseases, University Hospital of Padova
Last Updated: N/A
View Study Details

Effect of SGLT2 Inhibitor on Blood Glucose Profile in Type 2 Diabetic Patients Using Basal Insulin

Unknown Status
Last Known: NOT_YET_RECRUITING
Conditions:Type2 Diabetes
Interventions:SGLT2 inhibitor
Study Type:
INTERVENTIONAL
Phase:
PHASE4
Enrollment: 100
Age: N/A
Gender: ALL
Locations: N/A
Last Updated: N/A
View Study Details

Effects of Diabetes Medications on Adrenal Function and Intestinal Microbiota

Completed
Conditions:Type 2 Diabetes
Study Type:
OBSERVATIONAL
Phase: N/A
Enrollment: 23
Age: From 18 Years
Gender: ALL
Locations: Tartu University Hospital
Last Updated: N/A
View Study Details

Mechanism of SGLT2 Inhibition in the Kidney

Recruiting
Interventions:SGLT2 inhibitor
Study Type:
INTERVENTIONAL
Phase:
PHASE4
Enrollment: 20
Age: 18 Years - 80 Years
Gender: ALL
Locations: University of Michigan
Last Updated: N/A
Join Study

Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Diseases or Type 2 Diabetes

Recruiting
Study Type:
INTERVENTIONAL
Phase:
PHASE4
Enrollment: 92
Age: 50 Years - 85 Years
Gender: ALL
Locations: Yonsei University College of Medicine
Last Updated: N/A
Join Study